SymKardia, Inc. has announced a new offering of $4 million in convertible notes and equity, as detailed in its recent SEC filing. This strategic move is aimed at raising capital to support the company's growth initiatives.

Founded in 2024 and based in Westlake, Ohio, SymKardia, Inc. operates in the Other Health Care sector. The company is incorporated in Delaware and has a fiscal year that ends on December 31. The firm has filed several recent documents, including a Form D/A on October 28, 2026, and a Form D earlier that same day.

The filing states, "Rule 506(b) provides a 'safer harbor' for a private offering," indicating the regulatory framework under which the offering is being made. The total offering amount is $4 million, with all of it already sold, leaving no remaining amount to be offered.

This offering may affect the company's existing and potential investors, as it provides an opportunity for investment in convertible notes and equity. The filing notes that there are currently eight investors involved in this offering, and it does not include non-accredited investors.

Looking ahead, the filing does not specify what happens next regarding the use of proceeds or any further developments related to this offering.